Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
NCT00466518
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant
Type 2 Diabetes
Interventions
DRUG:
Administration of sitagliptin
Sponsor
University of Oklahoma